Patton Albertson Miller Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Patton Albertson Miller Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-17,767	Closed	-$892K	–	132
2016 Q2	$892K	Sell	17,767 -9,218	-34%	-$491K	0.4%	68
2016 Q1	$1.44M	Sell	26,985 -919	-3%	-$53.9K	0.73%	47
2015 Q4	$1.83M	Sell	27,904 -37	-0.1%	-$2.29K	0.92%	37
2015 Q3	$1.58M	Sell	27,941 -7,387	-21%	-$479K	0.84%	42
2015 Q2	$2.09M	Sell	35,328 -12	-0%	-$740	0.91%	48
2015 Q1	$2.2M	Buy	35,340 +6,075	+21%	+$353K	0.89%	49
2014 Q4	$1.68M	Buy	29,265 +11,433	+64%	+$637K	0.78%	48
2014 Q3	$955K	Buy	17,832 +7,581	+74%	+$402K	0.5%	77
2014 Q2	$542K	Buy	10,251 +566	+6%	+$28.9K	0.27%	111
2014 Q1	$512K	Sell	9,685 -1,935	-17%	-$89.4K	0.27%	94
2013 Q4	$466K	Buy	11,620 +3,395	+41%	+$134K	0.27%	88
2013 Q3	$311K	Buy	+8,225	New	+$321K	0.18%	101

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Patton Albertson Miller Group's TEVA Position: Q3 2016 in Review

Patton Albertson Miller Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2016, closing a stake of 17,767 shares — an estimated $892K sold.

Patton Albertson Miller Group first reported a position in TEVA in Q3 2013 and held it in 12 quarters. The position peaked at $2.2M in Q1 2015. 798 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Patton Albertson Miller Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2016 after selling out during the quarter.
Patton Albertson Miller Group sold 17,767 Teva Pharmaceutical Industries Limited shares in Q3 2016, an estimated $892K.
Patton Albertson Miller Group first reported a position in Teva Pharmaceutical Industries Limited in Q3 2013 and held it in 12 quarters.
Patton Albertson Miller Group's Teva Pharmaceutical Industries Limited position peaked at $2.2M in Q1 2015.
798 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2016.

Based on Patton Albertson Miller Group's 13F filing for Q3 2016, filed 10 Nov 2016.